ALLIQUA BIOMEDICAL INC - COM NEW (ALQA)

CUSIP: 019621200

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Equity / COM NEW
Total 13F shares
8,789,791
Share change
-1,612,098
Total reported value
$9,844,000
Price per share
$1.12
Number of holders
28
Value change
-$1,356,406
Number of buys
10
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 019621200?
CUSIP 019621200 identifies ALQA - ALLIQUA BIOMEDICAL INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ALLIQUA BIOMEDICAL INC - COM NEW (ALQA) as of Q2 2016

As of 30 Jun 2016, ALLIQUA BIOMEDICAL INC - COM NEW (ALQA) was held by 28 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,789,791 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, Tekla Capital Management LLC, SABBY MANAGEMENT, LLC, SUFFOLK CAPITAL MANAGEMENT LLC, PURA VIDA INVESTMENTS, LLC, J. Goldman & Co LP, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, US BANCORP \DE\, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 28 institutional shareholders reporting positions in this security for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.